These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30989996)

  • 1. [Research on patent quality of Chinese listed traditional Chinese medicine enterprises from R&D investment perspective].
    Cao YD; Gong RJ; Chen N; Liu W
    Zhongguo Zhong Yao Za Zhi; 2019 Mar; 44(6):1284-1288. PubMed ID: 30989996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of patent data of Panax notoginseng and enlightenment of industrial development].
    Li G; Chen J; Li ZK; Wu W; Yang HJ
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(5):1011-1022. PubMed ID: 32237440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research on the impact mechanism of heterogeneous environmental regulation on enterprise green technology innovation.
    Wang L; Long Y; Li C
    J Environ Manage; 2022 Nov; 322():116127. PubMed ID: 36067664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current situation and consideration of patent protection in classical representative famous prescriptions in China].
    Zhao SM; Song JX; DU MB; Yuan YN
    Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(18):4067-4071. PubMed ID: 31872747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Response to US review rules on patent subject matter of traditional Chinese medicine compositions].
    Liu P; Cao YD; Gong RJ; Liu W
    Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(3):627-630. PubMed ID: 29600632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research on competitiveness of traditional Chinese medicine industry's international trade based on diamond theory].
    Cheng M; Yang G; Chi XL; Xin MT
    Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(1):199-203. PubMed ID: 30868833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development and application of component-based Chinese medicine theory].
    Zhang JH; Fan GW; Zhang H; Fan XH; Wang Y; Liu LM; Li C; Gao Y; Gao XM; Zhang BL
    Zhongguo Zhong Yao Za Zhi; 2017 Nov; 42(21):4054-4058. PubMed ID: 29271139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current quality research situation of precious Chinese patent medicine].
    Lin L; Liu XQ; Xu H
    Zhongguo Zhong Yao Za Zhi; 2008 Feb; 33(3):329-33. PubMed ID: 18536475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thoughts of the combination of medicine and engineering and collaborative innovation on surgery in China].
    Lyu ZJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):562-565. PubMed ID: 32521975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financing innovation and enterprises' efficiency of technological innovation in the internet industry: Evidence from China.
    Piao Z; Lin Y
    PLoS One; 2020; 15(9):e0239265. PubMed ID: 32931512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis and design of signaling transfer mechanism based on third-party certification: quality prestige index of traditional Chinese medicine enterprises].
    Yang G; Wang N; Guo LP; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):925-8. PubMed ID: 25204192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current service invention patents and growth pathways on basis of cluster analysis].
    Yang XJ; Xiao SY
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(17):2656-60. PubMed ID: 23236772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incentive effect of tax preferences towards the technological innovation of enterprises--Based on China's GEM listed companies.
    Ding L; Wu Y; Long J
    PLoS One; 2023; 18(4):e0282692. PubMed ID: 37058543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Does the Concentration of Determinants Affect Industrial Innovation Performance? - An Empirical Analysis of 23 Chinese Industrial Sectors.
    Huang S; Bai Y; Tan Q
    PLoS One; 2017; 12(1):e0169473. PubMed ID: 28099452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does green credit affect the green innovation performance of high-polluting and energy-intensive enterprises? Evidence from a quasi-natural experiment.
    Liu S; Xu R; Chen X
    Environ Sci Pollut Res Int; 2021 Dec; 28(46):65265-65277. PubMed ID: 34231142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promote Green Innovation in Manufacturing Enterprises in the Aspect of Government Subsidies in China.
    Sun X; Tang J; Li S
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exploration and practice of post-marketing survival benefit evaluation of Chinese patent medicine for cancer].
    Xu BW; Wu JY; Li J; Zhang Y; Cao LC; Zhang XX; Gao RK
    Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):1980-1987. PubMed ID: 33982508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of model for multidimensional evaluation of value and risk of Chinese patent medicine].
    Li G; Li ZK; Yang HJ; Zhan ZL; Li HM; Tang SH
    Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(5):1284-1292. PubMed ID: 33787124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analyses on positive influence of harmonous development of traditional Chinese medicine compounds' researchs and patent protection].
    Yang X; Xiao S; Guo Z; Wang Z; You Y
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):9-12. PubMed ID: 22741453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capital allocation efficiency, technological innovation and vehicle carbon emissions: Evidence from a panel threshold model of Chinese new energy vehicles enterprises.
    Zhao M; Sun T; Feng Q
    Sci Total Environ; 2021 Aug; 784():147104. PubMed ID: 33892319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.